Langmuir-Blodgett Technology for Drugs Production and Delivery: Insights and Implications from an In Silico Study

Abstract

Insulin dynameomics here reported as a database pertaining to a series of Molecular Dynamics (MD) ran for Protein Data Bank (PDB) entries consisting in bioinformatics and molecular dynamics simulation of Langmuir-Blodgett and classical insulin with and without insulin receptor, appears to have profound implications for drug design and endocrinology. The slight differences in conformation and dynamics here reported may indeed explain why LB-insulin is more stable when binds to its receptor (lower free energy) and this could be useful when designing new drugs and pharmaceuticals.